
Neuphoria Therapeutics Inc. (NEUP)
- Previous Close
3.4200 - Open
3.4000 - Bid 3.8900 x 100
- Ask 3.9600 x 100
- Day's Range
3.3400 - 3.4200 - 52 Week Range
3.1900 - 19.2100 - Volume
16,172 - Avg. Volume
161,656 - Market Cap (intraday)
18.128M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-3.0600 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 10/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
19.91M
-
Enterprise Value
82.52k
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
13.78
-
Price/Book (mrq)
0.81
-
Enterprise Value/Revenue
0.07
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-19.66%
-
Return on Equity (ttm)
-61.70%
-
Revenue (ttm)
1.17M
-
Net Income Avi to Common (ttm)
-13.45M
-
Diluted EPS (ttm)
-3.0600
Balance Sheet and Cash Flow
-
Total Cash (mrq)
19.87M
-
Total Debt/Equity (mrq)
0.14%
-
Levered Free Cash Flow (ttm)
-8.34M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.

